|
Lab Update! Retractions from the October 15th edition of The Loop:
Phase II of the Histocompatibility and Immunogenetics Laboratory (HIL) test insourcing for Thoracic Transplant and Immunogenetics Testing has been delayed due to issues stemming from the US Government shutdown. At the time of this publication, we do not have a definitive go-live date; however, we will communicate this as soon as it becomes available. During this delay, testing will continue to be sent to DCI Laboratories.
The December go-live for urine drug confirmation testing has been pushed to February 10, 2026, due to delays in analysis software implementation. During this delay, testing will continue to be sent to ARUP Laboratories.
|
|
Please review the upcoming Test Changes, share updates with colleagues and staff members as appropriate, and implement necessary workflow changes by the specified effective dates.
|
Effective Date
| Test ID
Test Name | Change Type & Files |
| December 3, 2025 | LAB210, LAB212
Body Fluid Cell Count,
CSF Cell Count
|
INTERPRETIVE DATA | | October 22, 2025 | LAB6638
Blastomyces Antigen Quantitative by EIA, Urine
|
INACTIVATION WITH REPLACEMENT
| | November 19, 2025 |
LAB8632 Bordetella pertussis and parapertussis by PCR |
NEW TEST | | November 19, 2025 | LAB8630 Legionella species by PCR |
NEW TEST | | December 3, 2025 | LAB4155, LAB1749A Manual Differential and Differential, Morphology |
CRITICAL VALUE | | November 19, 2025 |
LAB8631 Mycoplasma pneumoniae by PCR |
NEW TEST | | December 10, 2025 | LAB129 Thyroid Stimulating Hormone (TSH), Serum |
METHODOLOGY
| | December 10, 2025 |
LAB127 Thyroxine, Free (Free T4), Serum |
METHODOLOGY | | December 19, 2025 |
LAB8665 Neutrophil Gelatinase-Associated Lipocalin (NGAL), Urine |
NEW TEST
|
|
|
|
© 2025 VUMC. All Rights Reserved.
|
|
|
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
445 Great Circle Rd | Nashville, TN 37228 US
|
|
|
This email was sent to tom.peters@vumc.org.
To continue receiving our emails, add us to your address book.
|
|
|
|